Sign in
4

Changes in Ownership

Amphastar Pharmaceuticals, Inc. Filed Acc 0001263136-26-000018

CFO, EVP & TREASURER sold 11,000 shares at $29.99 ($329,890)

  • CFO, EVP & TREASURER acquired 11,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

PETERS WILLIAM J · CFO, EVP & TREASURER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-16 Exercise or conversion : show line 1 in the form 10b5-1 +11,000 $17.99 $197,890 178,076 D
2026-11-16 Sale : show line 2 in the form 10b5-1 −11,000 $29.99 $329,890 167,076 D
Open-market sales · 11,000 sh · avg $29.99 · $329,890

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2026-11-16 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) −11,000 $17.99 2031-03-17 11,000 56,833 D
Loading xslF345X06/form4-11182026_091142.xml…